Pyrrolo [3,2-C] pyridine-4-one 2-indolinone protein kinase inhibitors
    6.
    发明授权
    Pyrrolo [3,2-C] pyridine-4-one 2-indolinone protein kinase inhibitors 有权
    吡咯并[3,2-C]吡啶-4-酮2-二氢吲哚酮蛋白激酶抑制剂

    公开(公告)号:US08362251B2

    公开(公告)日:2013-01-29

    申请号:US13196386

    申请日:2011-08-02

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and their pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8 X, Y and have the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).

    摘要翻译: 本发明涉及式(I)的吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,R8 X,Y并具有说明书中引用的含义。 还公开了含有前述化合物的药物组合物,其制备方法和药物用途,特别是蛋白激酶抑制剂。 式(I)。

    Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
    7.
    发明授权
    Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors 有权
    吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮蛋白激酶抑制剂

    公开(公告)号:US08012966B2

    公开(公告)日:2011-09-06

    申请号:US12223180

    申请日:2007-01-24

    CPC分类号: C07D471/04

    摘要: The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and their pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8X, Y and have the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).

    摘要翻译: 本发明涉及式(I)的吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,R8X ,Y并具有说明书中引用的含义。 还公开了含有前述化合物的药物组合物,其制备方法和药物用途,特别是蛋白激酶抑制剂。 式(I)。

    Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors
    8.
    发明申请
    Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors 有权
    吡咯并[3,2-C]吡啶-4-酮2-二氢吲哚酮蛋白激酶抑制剂

    公开(公告)号:US20100004239A1

    公开(公告)日:2010-01-07

    申请号:US12223180

    申请日:2007-01-24

    CPC分类号: C07D471/04

    摘要: The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and their pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8X, Y and have the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).

    摘要翻译: 本发明涉及式(I)的吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,R8X ,Y和具有说明书中引用的含义。 还公开了含有前述化合物的药物组合物,其制备方法和药物用途,特别是蛋白激酶抑制剂。 式(I)。

    Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
    9.
    发明授权
    Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors 有权
    吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮蛋白激酶抑制剂

    公开(公告)号:US08697692B2

    公开(公告)日:2014-04-15

    申请号:US13196391

    申请日:2011-08-02

    CPC分类号: C07D471/04

    摘要: The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and their pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8 X, Y and have the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).

    摘要翻译: 本发明涉及式(I)的吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,R8 X,Y并具有说明书中引用的含义。 还公开了含有前述化合物的药物组合物,其制备方法和药物用途,特别是蛋白激酶抑制剂。 式(I)。

    PYRROLO [3,2-C] PYRIDINE-4-ONE 2-INDOLINONE PROTEIN KINASE INHIBITORS
    10.
    发明申请
    PYRROLO [3,2-C] PYRIDINE-4-ONE 2-INDOLINONE PROTEIN KINASE INHIBITORS 有权
    吡咯并[3,2-C]吡啶-4-酮2-吲哚啉酮蛋白激酶抑制剂

    公开(公告)号:US20110301353A1

    公开(公告)日:2011-12-08

    申请号:US13196386

    申请日:2011-08-02

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds of Formula (I) and their pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8 X, Y and have the meaning cited in the specification. Also disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation and pharmaceutical use thereof, particularly as protein kinase inhibitors. Formula (I).

    摘要翻译: 本发明涉及式(I)的吡咯并[3,2-c]吡啶-4-酮2-二氢吲哚酮化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,R8 X,Y并具有说明书中引用的含义。 还公开了含有前述化合物的药物组合物,其制备方法和药物用途,特别是蛋白激酶抑制剂。 式(I)。